Headline
The latest stories from AHA Today.
Hospitals and other organizations have responded to COVID-19 by leveraging technology to expand outreach to patients and communities.
Johnson & Johnson announced it accelerated the initiation of its first human trials of its coronavirus vaccine candidate, with the trial slated to begin in the second half of July.
The National Institute on Minority Health and Health Disparities opened applications for supplemental funding to evaluate interventions to reduce COVID-19’s impact on populations that experience health disparities or other populations vulnerable to COVID-19 infection, hospitalization, or mortality…
The National Institute on Minority Health and Health Disparities opened applications for supplemental funding to evaluate interventions to reduce COVID-19’s impact on populations that experience health disparities or other populations vulnerable to COVID-19 infection, hospitalization, or mortality…
The White House Supply Chain Task Force projects the nation will have enough N95 masks to meet pandemic demand for July through October, according to a report released to the Senate Homeland Security and Governmental Affairs Committee for a hearing on federal efforts to procure and distribute…
AHA submitted comment to the Centers for Medicare & Medicaid Services on the agency’s proposed skilled nursing facility prospective payment system for fiscal year 2021, urging CMS to support additional funds to offset the cost of critically important COVID-19 testing.
The Internal Revenue Service released proposed regulations addressing the treatment of direct primary care arrangements, health care sharing ministry memberships and certain government-sponsored health care programs under section 213 of the Internal Revenue Code.
Each June “What Matters to You?” Day aims to encourage meaningful conversations between people who provide and receive health and social care.
The Food and Drug Administration does not intend to object to a manufacturer or authorized distributor delivering prescription drug samples directly to licensed practitioners or their patients at their homes during the COVID-19 emergency when requested by the practitioner in accordance with…
The Centers for Medicare & Medicaid Services released a guide for patients considering in-person, non-emergency treatment as the country continues to reopen and COVID-19 cases decline.